Analyzing CVS Health Corp 2024 Stock and CVS Health Corporation Dividend

CVS Health Corp Inc - CVS - Market Position

--- scroll --->
Stock Ticker Home Page Asset Class Sector Industry Investment Strategy Dividend Frequency Geographic Focus
CVS CVS Health Corporation Equity / Stock Healthcare Health Care Providers & Services Retail pharmacy, healthcare services Quarterly United States

CVS Health Corporation is a renowned healthcare company that operates a chain of retail pharmacies, as well as providing pharmacy benefit management services and healthcare clinics. One of the key attractions for investors is the company's consistent dividend payments, which have been increasing over the years.

CVS has a long history of rewarding its shareholders with dividends, having paid dividends for over three decades. The company's strong cash flow generation and resilient business model have enabled it to maintain a stable dividend payout ratio, even during challenging economic times. Additionally, CVS has demonstrated a commitment to growing its dividends, with an average annual dividend growth rate of around 20% over the past five years. This consistent dividend growth not only provides investors with a steady stream of income but also reflects the company's confidence in its future prospects. As the healthcare industry continues to evolve, CVS's diversified offerings in retail pharmacy, pharmacy benefit management, and healthcare services position it well to capitalize on emerging opportunities, further strengthening its ability to sustain and potentially increase its dividend payments in the years to come.

CVS Health Corp Inc - CVS - Current Market Data

CVS Health Corp - CVS - Business Overview

--- scroll --->
Section Information


CVS Health reigns as the leading retail pharmacy giant in the U.S., serving around one in three Americans through its expansive network of 9,600+ stores. Beyond traditional prescription fulfillment, CVS offers a comprehensive suite of healthcare services, including MinuteClinic walk-in clinics, chronic disease management programs, and immunizations. Its mission statement – "Helping People on Their Path to Better Health" – reflects its commitment to accessible and affordable healthcare for all.

Business Model:

CVS generates revenue primarily through:

  • Pharmacy services: Dispensing prescription and over-the-counter medications, garnering significant bargaining power with drug manufacturers.
  • Retail sales: Offering front-of-store merchandise like beauty products, groceries, and household essentials.
  • Healthcare services: MinuteClinic visits, vaccinations, and chronic disease management programs provide recurring revenue streams.

CVS leverages its vast scale and partnerships with key suppliers to secure favorable pricing and optimize its supply chain.

Industry Competition:

CVS faces competition from:

  • Traditional pharmacy chains: Walgreens, Rite Aid
  • Online pharmacies: Amazon Pharmacy, GoodRx
  • Healthcare providers: Clinics, direct-to-consumer telemedicine platforms

Recent trends, including rising demand for online prescription fulfillment and value-based healthcare services, shape the competitive landscape.

Competitive Advantages:

  • Dominant Market Share: CVS boasts a vast physical footprint and brand recognition, granting significant customer loyalty and purchasing power.
  • Diversified Revenue Streams: The mix of pharmacy services, retail sales, and healthcare services mitigates dependence on any single revenue source.
  • Integrated Healthcare Offerings: Combining retail pharmacies with MinuteClinic and disease management programs creates a convenient and accessible one-stop healthcare destination.
  • Digital Transformation: CVS is actively developing its online platforms, mobile apps, and delivery services to compete effectively in the e-commerce space.

Management Team:

CVS is led by CEO Karen Lynch, a healthcare executive with extensive experience in strategy, operations, and customer engagement. The management team boasts expertise in pharmacy, retail, technology, and healthcare services, demonstrating a well-rounded leadership approach.

Financial Performance:

As of December 28, 2023:

  • Revenue: $309.7 billion (FY2023)
  • Net Income: $7.7 billion (FY2023)
  • Earnings per Share (EPS): $4.42 (FY2023)
  • Dividend Yield: 2.9%

CVS exhibits consistent top-line growth, stable profitability, and a commitment to shareholder value through its 15-year track record of consecutive dividend increases.

Investment Thesis:

  • Reliable Income & Defensive Stability: CVS's established market position, diversified revenue streams, and consistent dividend history offer a defensive play with predictable income generation.
  • Healthcare Exposure: Its focus on essential healthcare services provides stability during economic downturns and capitalizes on the long-term growth potential of the healthcare sector.
  • Growth Potential: Investments in digital platforms, MinuteClinic expansion, and value-based care initiatives point towards potential future revenue and market share gains.


CVS Health's dominant market share, diversified revenue streams, and focus on evolving healthcare services solidify its position as a healthcare leader. For investors seeking reliable income with defensive stability and exposure to the growing healthcare sector, CVS presents a compelling option. However, the moderate yield and slower growth potential compared to higher-risk alternatives should be considered. Remember, diversification and individual circumstances remain crucial for informed investment decisions.

CVS Dividend Analysis

--- scroll --->
Section Details

CVS Dividend Data

CVS Health Corporation (CVS) has an annual dividend of $2.42 per share. The dividend is paid every three months. The last ex-dividend date was on January 23, 2024.

CVS Dividend Yield

The forward yield of CVS is 3.21%. This means that for every $100 invested in the company's stock, investors would receive $3.21 in dividends per year.

CVS Dividend History

CVS Health Corporation has a consistent history of paying dividends. The company has increased its dividends for 15 consecutive years. The most recent quarterly dividend payment of $0.605 per share was made to shareholders on Tuesday, February 1, 2024.

CVS Dividend Payout & Dividend Payout Ratio

The dividend payout ratio for CVS is 35.73% based on the trailing year of earnings. This means that 35.73% of the company's earnings are paid out as dividends.

CVS Dividend Growth

Over the past three years, the company's dividend has grown by an average of 5.83% per year. The most recent change in the company's dividend was an increase of $0.03 on Tuesday, December 6, 2023.

CVS Dividend Stability

CVS Health Corporation's dividend has shown stability with its consistent growth over the years. The company has a track record of raising its dividend for the past 15 consecutive years. This is a positive sign of the company's financial stability and its ability to pay consistent dividends in the future.

CVS Chart

CVS Comparative Analysis

--- scroll --->
Category CVS Health (CVS) Walgreens Boots Alliance (WBA) Rite Aid (RAD) GoodRx Holdings (GDRX)
Investment Focus Retail pharmacy, Pharmacy benefit management, Healthcare clinics Retail pharmacy, Wholesale distribution, Healthcare services Retail pharmacy, Pharmacy benefit management Digital healthcare platform, Prescription savings
Forward Dividend Yield Approximately 3.5% Approximately 4.73% -- --
P/E Ratio Approximately 11.61 Approximately 31.83 -- --
Strengths Diversified business model, Strong market share, Vertical integration Global presence, Diverse product offerings, Cost-saving initiatives Retail pharmacy network, Pharmacy benefit management Innovative technology platform, Cost-saving solutions
Weaknesses Regulatory changes, Competition, Reimbursement pressures Intense competition, Reimbursement pressures, Regulatory changes Financial constraints, Intense competition, Declining market share Limited revenue streams, Dependence on partnerships

Healthcare Stocks



Technical Analysis

Additional Considerations: Weighing the Risks

It's important to consider several factors when evaluating CVS's dividend performance. The next ex-dividend date has not been announced yet, but CVS Health Corp distributed a dividend payment of 0.67 per share on Feb 01, 2024 to shareholders who owned CVS Health Corp stock before Jan 19. This per share dividend represents a 3.3% yield on cost, and CVS's dividend payout ratio is 28.38% of the past year's earnings per share of 2.48.

While this information is provided solely for informational purposes and not as financial advice, it's crucial to analyze CVS's financial position, future growth prospects, and historical data on dividends paid and payout frequency. The company's ability to maintain a sustainable dividend payout ratio and its commitment to dividends, share buybacks, and stability and growth should be considered. Investors may want to add CVS to their watchlist to be reminded of upcoming payment dates and monitor the company's financial health and any changes to its dividend policy.